niacinamide has been researched along with Hodgkin Disease in 7 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Relapsed/refractory Hodgkin's lymphoma (HL) is an unmet medical need requiring new therapeutic options." | 1.40 | BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts. ( Anichini, A; Carbone, A; Carlo-Stella, C; Cleris, L; Locatelli, SL; Malorni, W; Pierdominici, M; Saba, E; Stirparo, GG; Tartari, S, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Locatelli, SL | 2 |
| Cleris, L | 2 |
| Stirparo, GG | 1 |
| Tartari, S | 1 |
| Saba, E | 1 |
| Pierdominici, M | 1 |
| Malorni, W | 1 |
| Carbone, A | 1 |
| Anichini, A | 2 |
| Carlo-Stella, C | 2 |
| Ullrich, K | 1 |
| Wurster, KD | 1 |
| Lamprecht, B | 1 |
| Köchert, K | 1 |
| Engert, A | 1 |
| Dörken, B | 1 |
| Janz, M | 1 |
| Mathas, S | 1 |
| Holz, MS | 1 |
| Janning, A | 1 |
| Renné, C | 1 |
| Gattenlöhner, S | 1 |
| Spieker, T | 1 |
| Bräuninger, A | 1 |
| Giacomini, A | 1 |
| Guidetti, A | 1 |
| Mortarini, R | 1 |
| Gianni, AM | 1 |
| IVANOVA, VD | 1 |
| RAUSHENBAKH, MO | 1 |
| Muggeo, M | 2 |
| De Antoni, A | 2 |
| Allegri, G | 2 |
| Costa, C | 2 |
| Crepaldi, G | 2 |
7 other studies available for niacinamide and Hodgkin Disease
| Article | Year |
|---|---|
BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Carbamates; Cell Line, Tum | 2014 |
BAY 43-9006/Sorafenib blocks CSF1R activity and induces apoptosis in various classical Hodgkin lymphoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Benzenesulfonates; Cell Line, Tumor; Hodgkin Disease; Humans; Niac | 2011 |
Induction of endoplasmic reticulum stress by sorafenib and activation of NF-κB by lestaurtinib as a novel resistance mechanism in Hodgkin lymphoma cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carbazoles; Cell Line, Tumor; Drug Intera | 2013 |
Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspases; Cell Cycle Proteins; C | 2013 |
[TRYPTOPHAN METABOLISM IN LEUKEMIA].
Topics: Anemia; Anemia, Aplastic; Chromatography; Drug Therapy; Hodgkin Disease; Humans; Indoles; Leukemia; | 1964 |
The influence of nicotinamide on the urinary excretion of tryptophan metabolites in Hodgkin's disease.
Topics: Adolescent; Adult; Amino Acids; Female; Hodgkin Disease; Humans; Kynurenine; Male; Metabolism; Middl | 1970 |
The influence of simultaneous administration of vitamin B 6 and nicotinamide on tryptophan metabolism in Hodgkin's disease.
Topics: Acylation; Administration, Oral; Aminohippuric Acids; Hodgkin Disease; Humans; Hydroxylation; Infusi | 1972 |